Category: Macular Degeneration Research Advances
Ocugen Clinical Trial Could Lead to Breakthrough One-Time Treatment for Advanced Dry Macular Degeneration
NORTHAMPTON, Ma., Dec. 19, 2023 — The American Macular Degeneration Foundation received news that the first patient has been dosed in a safety and efficacy clinical trial of a one-time gene therapy treatment for advanced dry macular degeneration (dry AMD), also known as Geographic Atrophy (GA). What’s exciting about this trial is that, if successful,…